Isoxazole-type derivatives related to combretastatin A-4, synthesis and biological evaluation

被引:136
作者
Kaffy, Julia
Pontikis, Renee
Carrez, Daniele
Croisy, Alain
Monneret, Claude
Florent, Jean-Claude
机构
[1] Inst Curie, CNRS, UMR 176, Ctr Rech, F-75248 Paris 05, France
[2] Ctr Univ Orsay, INSERM, Inst Curie, Ctr Rech,Lab Raymond Latarjet,U759, F-91405 Orsay, France
关键词
combretastatin; isoxazole; 1,3-dipolar cycloaddition tubulin; cytotoxicity;
D O I
10.1016/j.bmc.2006.02.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Novel combretastatin analogues bearing various five-membered heterocycles with consecutive oxygen and nitrogen atoms, in place of the olefinic bridge of CA4, have been synthesized (isoxazole, isoxazoline, oxadiazole, etc). These compounds have been evaluated for cytotoxicity and their ability to inhibit the tubulin assembly. On the basis of the relative position of the aromatic A- and B-rings on the heterocyclic moiety, they could be split in two classes, the alpha,gamma- or alpha,beta-diaryl heterocyclic derivatives. In the first series, the 3,5-diaryloxadiazole 9a displayed comparable antitubulin activity to that of CA4, but was devoid of cytotoxic effects. Among the alpha,beta-diaryl heterocyclic derivatives, the 4,5-diarylisoxazole 35 exhibited greater antitubulin activity than that of CA4 (0.75 vs 1.2 mu M), but modest antiproliferative activity. These data showed that minor alteration in the chemical structure of the heterocyclic ring and its relative orientation with regard to the two phenyl rings of CA4 could dramatically influence the tubulin binding properties. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4067 / 4077
页数:11
相关论文
共 54 条
[1]  
Beauregard DA, 2001, CANCER RES, V61, P6811
[2]   ISOXAZOLINE DERIVATIVES .6. REGIOSELECTIVITY IN 1,3-DIPOLAR CYCLOADDITION OF NITRILE OXIDES TO ALPHA,BETA-UNSATURATED KETONES [J].
BIANCHI, G ;
DEMICHEL.C ;
GANDOLFI, R ;
GRUNANGER, P ;
VITAFINZ.P .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1973, (11) :1148-1155
[3]  
CAMPBELL MM, 1979, COMPREHENSIVE ORGANI, V4, P1004
[4]  
Chaplin DJ, 1999, ANTICANCER RES, V19, P189
[5]   4-hydroxymethyl-3-aminoacridine derivatives as a new family of anticancer agents [J].
Charmantray, F ;
Demeunynck, M ;
Carrez, D ;
Croisy, A ;
Lansiaux, A ;
Bailly, C ;
Colson, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (06) :967-977
[6]   RPR112378 and RPR115781: Two representatives of a new family of microtubule assembly inhibitors [J].
Combeau, C ;
Provost, J ;
Lancelin, F ;
Tournoux, Y ;
Prod'homme, F ;
Herman, F ;
Lavelle, F ;
Leboul, J ;
Vuilhorgne, M .
MOLECULAR PHARMACOLOGY, 2000, 57 (03) :553-563
[7]   1,3-cycloaddition of nitrile oxides in ionic liquids. An easier route to 3-carboxy isoxazolines, potential constrained glutamic acid analogues [J].
Conti, D ;
Rodriquez, M ;
Sega, A ;
Taddei, M .
TETRAHEDRON LETTERS, 2003, 44 (28) :5327-5330
[8]  
Dark GG, 1997, CANCER RES, V57, P1829
[9]   A convenient one-pot preparative method for 4,5-diarylisoxazoles involving amine exchange reactions [J].
Dominguez, E ;
Ibeas, E ;
deMarigorta, EM ;
Palacios, JK ;
SanMartin, R .
JOURNAL OF ORGANIC CHEMISTRY, 1996, 61 (16) :5435-5439
[10]  
FURSTNER A, 1995, J ORG CHEM, V60, P6637